BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2186841)

  • 1. Megestrol acetate in relapsed carcinoma of prostate.
    Daniel F; MacLeod PM; Tyrrell CJ
    Br J Urol; 1990 Mar; 65(3):275-7. PubMed ID: 2186841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megestrol acetate in the treatment of metastatic carcinoma of the prostate.
    Venner P
    Oncology; 1992; 49 Suppl 2():22-7. PubMed ID: 1461622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
    Smith JA
    J Urol; 1994 Jul; 152(1):132-4. PubMed ID: 8201642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megestrol acetate plus low-dose estrogen in the management of advanced prostatic carcinoma.
    Geller J
    Urol Clin North Am; 1991 Feb; 18(1):83-91. PubMed ID: 1825145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic options in treatment of advanced carcinoma of the prostate.
    Venner PM
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):73-7. PubMed ID: 2259929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of megestrol acetate for metastatic carcinoma of the prostate.
    Crombie C; Raghavan D; Page J; Woods R; Dalley D; Devine R; Rosen M
    Br J Urol; 1987 May; 59(5):443-6. PubMed ID: 3594101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical castration using megestrol acetate and minidose estrogen.
    Johnson DE; Babaian RJ; Swanson DA; von Eschenbach AC; Wishnow KI; Tenney D
    Urology; 1988 May; 31(5):371-4. PubMed ID: 3284149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Megestrol acetate used as primary hormonal therapy in stage D prostatic cancer.
    Bonomi P; Pessis D; Bunting N; Block M; Anderson K; Wolter J; Rossof A; Slayton R; Harris J
    Semin Oncol; 1985 Mar; 12(1 Suppl 1):36-9. PubMed ID: 3975650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.
    Seidman AD; Scher HI; Petrylak D; Dershaw DD; Curley T
    J Urol; 1992 Mar; 147(3 Pt 2):931-4. PubMed ID: 1371564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.
    Belinson JL; McClure M; Badger G
    Gynecol Oncol; 1987 Oct; 28(2):151-5. PubMed ID: 3311923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-treatment testosterone levels: significance in androgen deprivation therapy.
    Hickey D; Todd B; Soloway MS
    J Urol; 1986 Nov; 136(5):1038-40. PubMed ID: 3095566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.
    Venner PM; Klotz PG; Klotz LH; Stewart DJ; Davis IR; Orovan WL; Ramsey EW
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):62-7. PubMed ID: 3285485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.
    Rennie PS; Bruchovsky N; Goldenberg SL; Lawson D; Fletcher T; Foekens JA
    J Urol; 1988 Jun; 139(6):1337-42. PubMed ID: 2967378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate in the treatment of hormone refractory prostate cancer.
    Osborn JL; Smith DC; Trump DL
    Am J Clin Oncol; 1997 Jun; 20(3):308-10. PubMed ID: 9167760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate in the treatment of advanced post-menopausal breast cancer.
    Benghiat A; Cassidy SA; Davidson HE; Mancero FS; Pickard JG; Tyrrell CJ
    Eur J Surg Oncol; 1986 Mar; 12(1):43-5. PubMed ID: 3956753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate.
    Patel SR; Kvols LK; Hahn RG; Windschitl H; Levitt R; Therneau T
    Cancer; 1990 Aug; 66(4):655-8. PubMed ID: 2201425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of castration compared with total androgen blockade on tissue dihydrotestosterone (DHT) concentration in benign prostatic hyperplasia (BPH).
    Geller J; Albert J
    Urol Res; 1987; 15(3):151-3. PubMed ID: 3629749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megestrol acetate for the prevention of hot flashes.
    Loprinzi CL; Michalak JC; Quella SK; O'Fallon JR; Hatfield AK; Nelimark RA; Dose AM; Fischer T; Johnson C; Klatt NE
    N Engl J Med; 1994 Aug; 331(6):347-52. PubMed ID: 8028614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate for treatment of advanced carcinoma of the prostate.
    Johnson DE; Kaesler KE; Ayala AG
    J Surg Oncol; 1975; 7(1):9-15. PubMed ID: 1177459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megestrol acetate in advanced breast carcinoma.
    Espie M
    Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.